Anbio Biotechnology Logo

Anbio Biotechnology

Develops and supplies in vitro diagnostic solutions for human and veterinary markets.

NNNN | US

Overview

Corporate Details

ISIN(s):
KYG0367B1059
LEI:
Country:
United States of America
Address:
FRIEDRICH-EBERT-ANLAGE 49, 60308 FRANKFURT AM MAIN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anbio Biotechnology is a global medical technology company founded in 2021 that specializes in in vitro diagnostics (IVD). The company develops, manufactures, and supplies a diverse portfolio of diagnostic products for over-the-counter (OTC), point-of-care (POCT), and laboratory use, serving both human and veterinary markets. Its solutions are designed to detect a wide range of biomarkers across critical medical fields such as infectious diseases, cancer, cardiovascular diseases, and diabetes. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company's mission is to advance personalized and decentralized diagnostics to improve healthcare outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Anbio Biotechnology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anbio Biotechnology

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Anbio Biotechnology via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NeoImmuneTech, Inc. Logo
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America 950220
NEONC TECHNOLOGIES HOLDINGS, INC. Logo
Developing intranasal drug delivery to treat brain cancer & CNS diseases by crossing the BBB.
United States of America NTHI
Neumora Therapeutics, Inc. Logo
Developing data-driven precision medicines for neuropsychiatric and neurodegenerative disorders.
United States of America NMRA
Neuphoria Therapeutics Inc. Logo
Develops novel ion channel modulators for treating neuropsychiatric disorders like anxiety & PTSD.
United States of America NEUP
NEUROCRINE BIOSCIENCES INC Logo
Develops therapies for neurological, neuroendocrine, and neuropsychiatric disorders.
United States of America NBIX
Neurogene Inc. Logo
Developing genetic medicines using gene therapy for rare and devastating neurological diseases.
United States of America NGNE
NeuroSense Therapeutics Ltd. Logo
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America NRSN
NewAmsterdam Pharma Co N.V. Logo
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America NAMS
Newbury Pharmaceuticals AB Logo
Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.
Sweden NEWBRY
New Nordic Healthbrands AB Logo
Develops and markets herbal supplements & beauty products for natural wellness consumers globally.
Sweden NNH

Talk to a Data Expert

Have a question? We'll get back to you promptly.